Loestrin Buyers Teed Up For Appeal In Pay-For-Delay Suit

Law360, New York (February 18, 2015, 4:34 PM EST) -- A Rhode Island judge on Tuesday cleared the way for Loestrin buyers to appeal the dismissal of their pay-for-delay claims against Warner Chilcott PLC, which would see another circuit court forced to decide whether patent settlements must include cash payments to face antitrust scrutiny.

U.S. District Judge William E. Smith signed off on a mixture of final judgments and stays in a series of antitrust suits brought by pharmacies, health plans and drug cooperatives challenging Hatch-Waxman Act settlements Warner Chilcott inked with generic-drug makers Watson Pharmaceuticals Inc. and Lupin Pharmaceuticals Inc. over the oral contraceptive.

The result is that the putative...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!